fundraising >
Loading...
Loading investors...
16,371 investors
16,371 investors |
Geography | Checks | Stages | Lead | Investment thesis | Value add | Typical terms | Socials | Reply rate | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Amorchem VC firm | Canada | $100k to $5M | 3. Early Revenue 4. Scaling5. Growth | Sometimes | We invest in life sciences. |
|
Send email
| |||
![]() | Apollo Health Vent... | Switzerland Netherlands UK USA | $5k to $5M | 3. Early Revenue 4. Scaling | Sometimes | We invest in seed and early-stage biotechnology companies. | We accelerate biotech founders through a paid venture fellowship with hands-on venture building, expert mentorship, scientific validation funding, commercialization training, and access to a global biotech and investor network.
| We typically invest $5K–$5M in seed and Series A life sciences startups, usually in exchange for a 15%–25% equity stake as a lead investor, with ownership varying based on valuation, round structure, and level of involvement. For internally created ventures, equity ownership may exceed 50% through a venture-building model. |
|
Send email
| |
![]() | MatterScale Ventur... VC firm | Argentina Brazil Chile Colombia Mexico Peru Singapore UK USA | $150k to $750k | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in early-stage companies founded by Latin entrepreneurs. | We actively support our portfolio with Commercial intros and our enterprise network including Endeavor.
|
|
Send email
| ||
![]() | Supermoon Capital VC firm | Germany Israel Switzerland Netherlands USA | $250k to $2.5M | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in innovations within the sleep market. |
|
Send email
| |||
![]() | GK-Plug and Play I... VC firm | Indonesia Singapore UK | $25k to $500k | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in innovation platforms that connect startups and corporations. | A 12-week accelerator providing mentorship, business development support, corporate pilot opportunities, investor introductions, Demo Day exposure, office space, software and cloud credits, regulatory guidance, and access to Plug and Play’s global network of partners, investors, and innovation hubs.
| We typically invest $50K for a fixed 5% equity stake in early-stage startups through our accelerator program, with access to mentoring and corporate tools, while larger growth-stage investments (up to ~$500K) are negotiated on a custom valuation basis and certain corporate innovation tracks operate on a 0% equity, non-dilutive partnership model focused on pilot and enterprise collaboration. |
|
Send email
| |
![]() | Cortical Ventures VC firm | Germany Netherlands USA | $100k to $5M | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in artificial intelligence companies. |
|
Send email
| |||
![]() | Bija Ventures
VC firm | Canada USA UK | $100k to $1M | 2. Prototype 3. Early Revenue | Never | We invest in early-stage biotech platform companies around DC, supporting them from IND-enabling studies through first-in-human trials. We are modality and indication agnostic, focused on platforms that pair AI/ML with wet-lab validation. | We help founders cross the preclinical valley of death by providing both capital and operational support to get them to the next meaningful inflection point.
|
|
13% | Submit deck
| |
![]() | Takwin Ventures VC firm | Israel USA | $100k to $5M | 3. Early Revenue 4. Scaling | Sometimes | We invest in high-tech companies. |
|
Send email
| |||
![]() | Basinghall Partner...
VC firm | UK Germany Austria Portugal | $250k to $500k | 3. Early Revenue 5. Growth | Sometimes | We invest in B2B European Startups | Innovation Circle: We introduce our business network to our startup universe, connecting European industry with innovation.
|
|
| ||
![]() | Kairos HQ | UK USA | $100k to $5M | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in fintech, healthcare, and real estate, aiming to improve affordability and simplicity for consumers. | Problem identification and market validation; access to expert advisors and experienced operators; end-to-end company-building support; co-founding and operational infrastructure; direct consumer testing and feedback; brand development support.
|
|
Send email
| ||
![]() | Triatomic Capital | UK USA | $250k to $25M | 3. Early Revenue 4. Scaling | Sometimes | We invest in deep tech, health tech, and artificial intelligence, supporting entrepreneurs building transformative technologies and businesses. |
|
Send email
| |||
![]() | Open Circle Capita...
VC firm | Lithuania Latvia Estonia Finland | $100k to $1M | 3. Early Revenue 2. Prototype | Sometimes | We invest in early-stage startups in the Nordics and Baltics, focusing on digital health, industrial automation, and enterprise software sectors. | Open Circle Capital provides strong support through extensive industry experience, a strong network of advisors and co-founders, and a commitment to sustainability, ensuring startups achieve significant growth and impact.
|
|
| ||
![]() | Cervin Ventures
VC firm | USA Israel | $200k to $7M | 2. Prototype 3. Early Revenue | Sometimes | We invest in early-stage (Pre-Seed, Seed, Series A) enterprise, B2B technology. Sectors of focus include: vertical-specific SaaS, cybersecurity, infrastructure and tools, and CFO workflow softwware. We invest in companies based in, or focused on, the US market. | In addition to having partners actively working with founders, Cervin Ventures has a value-add platform team that focuses on go-to-market advisory work, business development introductions, recruiting and market research and analysis.
|
|
| ||
![]() | D44 Ventures
VC firm | USA | $100k to $5M | 1. Idea or Patent 2. Prototype3. Early Revenue4. Scaling | Sometimes | We invest in Neuroscience, Brain Health, BCI, Neurotech | We leverage our professional network and clinician network to help companies grow
|
|
| ||
![]() | The Fintech Fund VC firm | Argentina Brazil Canada Ghana India Mexico Nigeria Pakistan South Africa Netherlands Uganda UK USA | $150k to $200k | 2. Prototype 3. Early Revenue4. Scaling | Never | We invest in the best teams in fintech and decentralized finance (DeFi), leveraging blockchain technology. | We support founders with strategic guidance, early customer and partner introductions, fundraising support, and hands-on help during the build and go-to-market phases.
|
|
Send email
| ||
![]() | ADDF's Diagnostics... | Canada Spain Netherlands UK USA Israel | $100k to $3M | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in drug discovery, biotechnology, and life sciences research focused on Alzheimer's disease. | ADDF Diagnostics Accelerator provides access to clinical trial samples, expert consulting, regulatory guidance, industry partnerships, consortium collaborations, and a strong biotech network to help researchers and startups advance diagnostics from development to commercialization.
| We typically invest $100K–$3M+ in biotech startups, using customized terms such as convertible notes, direct equity, milestone-based agreements, or royalties rather than a fixed equity percentage, with terms aligned to the company and co-investors. |
|
Send email
| |
![]() | U-investors
VC firm | Côte d'Ivoire Nigeria Czech Republic Denmark Estonia Finland France Germany Greece Iceland Ireland Italy Lithuania Luxembourg Monaco Poland Portugal Switzerland Egypt Morocco Qatar Saudi Arabia UAE | $150k to $500k | 3. Early Revenue | Sometimes | We invest in Seed to pre-Series A startups, with MVP or POC and at least six months of revenue. Sector, agnostic but with a focus on Fintech, Insurtech, cybersecurity, IT, and AI. Geography: MENA, Europe (France, Switzerland, UK), and the USA. | Based on our experience and expertise, we coach the founders and help them reach the numbers on the BP so to get to the next level.
|
|
Submit deck
| ||
![]() | AdvantEdge Founder... | India Singapore USA | $60k to $1.5M | 2. Prototype 3. Early Revenue4. Scaling | Sometimes | We invest in early-stage startups. | AdvantEdge Founders provides founder-led mentorship, deep automotive and regulatory expertise, corporate pilot introductions, commercial validation, follow-on funding access, investor networks, and hands-on governance support.
| We typically invest $60K–$250K at pre-seed/incubation for around 5%–15% equity, and $500K–$1.5M at seed/Series A for around 15%–25% equity, with terms varying based on valuation and deal structure. |
|
Send email
| |
![]() | Shield Capital VC firm | Netherlands USA | $100k to $5M | 3. Early Revenue 4. Scaling | Sometimes | We invest in founders building frontier technologies. |
|
Send email
| |||
![]() | M&G Investments | Canada France Germany India Israel Kenya New Zealand Switzerland UK USA | $10M to $30M | 5. Growth 6. Pre-IPO4. Scaling | Sometimes | We invest capital where it counts: in privately owned businesses which have innovative solutions to the world's biggest environmental and social problems, with a focus on climate, health and tackling inequality. We are flexible, supportive long term investors and can provide equity or debt, to suit the changing needs of the business. With a $6 billion mandate, we focus on scale ups and growth opportunities with a cheque size of $20 million+ but can consider earlier stage businesses aligned with our core themes, particularly those with female founders or founders from other underrepresented groups. |
|
| |||

Canada
Switzerland
Netherlands
UK
USA
Argentina
Brazil
Chile
Colombia
Mexico
Peru
Singapore
Germany
Israel
Indonesia




Austria
Portugal


Lithuania
Latvia
Estonia
Finland


Ghana
India
Nigeria
Pakistan
South Africa
Uganda
Spain
Côte d'Ivoire
Czech Republic
Denmark
France
Greece
Iceland
Ireland
Italy
Luxembourg
Monaco
Poland
Egypt
Morocco
Qatar
Saudi Arabia
UAE


Kenya
New Zealand